URGENT UPDATE: Global leaders in biotechnology are set to converge in San Francisco on January 14, 2026, for the highly anticipated 5th Annual Biotech Global Forum, hosted by GenScript Biotech Corporation. This year’s forum, themed ‘Scripting Possibilities’, will explore groundbreaking advancements in cell and gene therapies and next-generation biotherapeutics.
The forum runs concurrently with the J.P. Morgan Healthcare Conference, making it a pivotal event for scientists, innovators, and investors to discuss transformative ideas in biotechnology. Attendees will engage in critical discussions on the intersection of discovery, computation, and therapeutic development, all aimed at creating real-world impacts for patients.
Sherry Shao, CEO of GenScript, emphasized the forum’s importance: “The Global Forum has become a central gathering point for leaders driving progress across the biotech ecosystem.” With both in-person and virtual attendance options available, this event is expected to draw significant participation from across the globe.
Keynote speakers at this year’s forum include David Baker, PhD, a Nobel Laureate in Chemistry (2024) and director of the Institute for Protein Design, and Eric Horvitz, PhD, MD, Chief Scientific Officer at Microsoft. Their insights into computational protein design and artificial intelligence will showcase how these technologies are revolutionizing therapeutic innovation.
Forum Highlights Include:
– A keynote address and fireside conversation on the future of AI and protein design.
– Insight-driven panel sessions focusing on cell and gene therapy advancements and AI-enabled drug discovery.
– A technology showcase featuring GenScript’s innovative Dark Lab and GenGenius+ automation platform.
– Networking opportunities designed to foster collaboration among biotech leaders and investors.
Ray Chen, PhD, President of GenScript Life Science Group, stated, “Biotechnology is at an inflection point – where speed, precision, and collaboration are no longer optional.” This sentiment underscores the urgency of the discussions that will take place, as leaders work to script the future of biomedicine.
Registration for the GenScript Biotech Global Forum is now open. For further details and to secure your place, visit GenScript’s official website.
With over 5,700 employees and a commitment to advancing biotechnology since its inception in 2002, GenScript continues to be a driving force in the industry, serving over 200,000 customers worldwide.
Stay tuned for further updates as this event approaches, and prepare to engage with the latest innovations shaping the future of healthcare!
